Phenotypic Alteration of Neutrophils in the Blood of HIV Seropositive Patients

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Cloke, Tom ^a   Munder, Markus ^b   Bergin, Philip ^c   Herath, Shanthi ^a   Modolell, Manuel ^d   Taylor, Graham ^a   Müller, Ingrid ^a   Kropf, Pascale ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c INTERNATIONAL AIDS VACCINE INITIATIVE   (United States)

^d MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; CD11B ANTIGEN; CD15 ANTIGEN; CD16 ANTIGEN; CD33 ANTIGEN; CD63 ANTIGEN; CD66B ANTIGEN; LYMPHOCYTE ANTIGEN; MICROSOMAL AMINOPEPTIDASE; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NEUTROPHIL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPIC VARIATION; VIRUS LOAD;

ADULT; ANTIGENS, CD13; ARGINASE; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; NEUTROPHILS; PHENOTYPE; SPECIFIC GRAVITY; VIRAL LOAD; YOUNG ADULT;

EID: 84883635470     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072034     Document Type: Article

References (24)

1. Drescher B, Bai F, (2012) Neutrophil in viral infections, friend or foe? Virus Res.
2. Kuritzkes DR, (2000) Neutropenia, neutrophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony-stimulating factor. Clin Infect Dis 30: 256-260.
3. Saitoh T, Komano J, Saitoh Y, Misawa T, Takahama M, et al. (2012) Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1. Cell Host Microbe 12: 109-116.
4. Munder M, Mollinedo F, Calafat J, Canchado J, Gil-Lamaignere C, et al. (2005) Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood 105: 2549-2556.
5. Cederbaum SD, Yu H, Grody WW, Kern RM, Yoo P, et al. (2004) Arginases I and II: do their functions overlap? Mol Gen Metabol 81: S38-S44.
6. Munder M, (2009) Arginase: an emerging key player in the mammalian immune system. Br J Pharmacol 158: 638-651.
7. Ochoa AC, Zea AH, Hernandez C, Rodriguez PC, (2007) Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin Cancer Res 13: 721s-726s.
8. Popovic PJ, Zeh HJ 3rd, Ochoa JB, (2007) Arginine and immunity. J Nutr 137: 1681S-1686S.
9. Bronte V, Zanovello P, (2005) Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol 5: 641-654.
10. Munder M, Choi BS, Rogers M, Kropf P, (2009) L-arginine deprivation impairs Leishmania major-specific T cell responses. European Journal of Immunology 39: 2161-2172.
11. Weinberg JB, Lopansri BK, Mwaikambo E, Granger DL, (2008) Arginine, nitric oxide, carbon monoxide, and endothelial function in severe malaria. Curr Opin Infect Dis 21: 468-475.
12. Zea AH, Culotta KS, Ali J, Mason C, Park HJ, et al. (2006) Decreased Expression of CD3 zeta and Nuclear Transcription Factor kappa B in Patients with Pulmonary Tuberculosis: Potential Mechanisms and Reversibility with Treatment. J Infect Dis 194: 1385-1393.
13. Abebe T, Hailu A, Woldeyes M, Mekonene W, Bilch K, et al. (2012) Local increase of arginase activity in lesions of patients with cutaneous leishmaniasis in Ethiopia. PLoS NTD 6: e1684.
14. Takele Y, Abebe T, Weldegebreal T, Hailu A, Hailu W, et al. (2012) Arginase activity in the blood of patients with visceral leishmaniasis and HIV infection. PLoS NTD 7 (1) (): e1977.
15. Abebe T, Takele T, Weldegebreal T, Cloke T, Closs E, et al. (2013) Arginase: a marker of disease status in patients with visceral leishmaniasis. PLoS NTD in press.
16. Cloke T, Garvery L, Choi BS, Abebe T, Hailu A, et al. (2010) Increased arginase activity correlates with disease severity in HIV seropositive patients. Journal of Infectious Diseases 202: 374-385.
17. Cloke T, Munder M, Taylor GP, Müller I, Kropf P, (2012) Characterization of a novel population of low-density granulocytes associated with disease severity in HIV seropositive patients. PLOS ONE 7: e48939.
18. Kropf P, Baud D, Marshall SE, Munder M, Mosley A, et al. (2007) Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy. Eur J Immunol 37: 935-945.
19. Phillips A, Pezzotti P, (2004) Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era. AIDS 18: 51-58.
20. Gazzard BG, (2008) British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Med 9: 563-608.
21. Elbim C, Prevot MH, Bouscarat F, Franzini E, Chollet-Martin S, et al. (1994) Polymorphonuclear neutrophils from human immunodeficiency virus-infected patients show enhanced activation, diminished fMLP-induced L-selectin shedding, and an impaired oxidative burst after cytokine priming. Blood 84: 2759-2766.
22. Rotondo R, Bertolotto M, Barisione G, Astigiano S, Mandruzzato S, et al. (2011) Exocytosis of azurophil and arginase 1-containing granules by activated polymorphonuclear neutrophils is required to inhibit T lymphocyte proliferation. J Leukoc Biol 89: 721-727.
23. Kuijpers TW, Tool AT, van der Schoot CE, Ginsel LA, Onderwater JJ, et al. (1991) Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation. Blood 78: 1105-1111.
24. Martin-Martin B, Nabokina SM, Blasi J, Lazo PA, Mollinedo F, (2000) Involvement of SNAP-23 and syntaxin 6 in human neutrophil exocytosis. Blood 96: 2574-2583.